NEREUS Trademark
Trademark Overview
On Monday, December 15, 2025, a trademark application was filed for NEREUS with the United States Patent and Trademark Office. The USPTO has given the NEREUS trademark a serial number of 99548441. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 26, 2026. This trademark is owned by Vanda Pharmaceuticals Inc.. The NEREUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases,
disorders, or conditions caused by an over-expression of the neuropeptide
known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of
the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of nausea in gastroparesis; Pharmaceutical preparations for the treatment of symptoms of gastroparesis; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion; Pharmaceutical preparations for the treatment of vomiting in gastroparesis; Pharmaceutical preparat...
General Information
| Serial Number | 99548441 |
| Word Mark | NEREUS |
| Filing Date | Monday, December 15, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 26, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases,
disorders, or conditions caused by an over-expression of the neuropeptide
known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of
the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of nausea in gastroparesis; Pharmaceutical preparations for the treatment of symptoms of gastroparesis; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion; Pharmaceutical preparations for the treatment of vomiting in gastroparesis; Pharmaceutical preparations for the treatment and prevention of nausea induced by motion |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 15, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037
US |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037
US |
Trademark Events
| Event Date | Event Description |
| Monday, December 15, 2025 | NEW APPLICATION ENTERED |
| Monday, December 15, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 15, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 17, 2026 | ASSIGNED TO EXAMINER |
| Monday, April 27, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 20, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
